Zepbound cost comparison vs Wegovy monthly price

Last Updated: January 2026 | Medical Reviewer: Sarah Mitchell, Healthcare Content Specialist | Disclaimer: This content is for informational purposes only and does not constitute medical advice. Please consult with a healthcare provider before starting any GLP-1 medication. Always verify current pricing with your pharmacy and insurance provider.

If you're considering GLP-1 medications for weight management, you've likely encountered both Zepbound and Wegovy—and wondered why the same medication carries different price tags and insurance coverage options. The truth is, navigating the cost landscape of these medications can feel overwhelming. Between retail prices ranging from $900 to $1,350 monthly, insurance copays varying from $50 to $250 per injection, and manufacturer savings programs offering rebates up to $550, understanding your actual out-of-pocket expenses requires detailed research. This comprehensive guide breaks down real pricing data, insurance coverage scenarios, and financial assistance programs to help you make an informed decision about which GLP-1 medication fits your budget and healthcare plan.

Understanding the Medication Basics and FDA Approvals

Before comparing costs, it's crucial to understand what you're paying for. Zepbound and Wegovy both contain the identical active ingredient: semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist manufactured by Novo Nordisk. However, their regulatory pathways and approvals differ slightly.

Wegovy received FDA approval on June 4, 2021, for chronic weight management in adults with obesity or overweight with related health conditions. Zepbound earned FDA approval on November 22, 2023, also for weight management purposes. Both medications are administered as subcutaneous injections once weekly, with available dose strengths of 0.25 mg, 0.5 mg, 1 mg, 1.7 mg, and 2.4 mg.

The dosing protocol follows an identical titration schedule for both medications, starting at 0.25 mg and increasing gradually over 16-20 weeks until reaching the maintenance dose of 2.4 mg. From a pharmaceutical perspective, they're bioequivalent products—meaning they deliver the same therapeutic effects. The cost differences you'll encounter stem from insurance negotiations, pharmacy networks, and manufacturer programs rather than differences in the medication itself.

Detailed Monthly Cost Breakdown: Insurance Coverage and Out-of-Pocket Expenses

Uninsured Retail Prices: Without insurance coverage, both medications carry similar price tags at major pharmacy chains. Current 2024-2025 data shows:

• Wegovy: $900-$1,100 per monthly injection at retail pharmacies
• Zepbound: $950-$1,350 per monthly injection at retail pharmacies

The variation depends on pharmacy location, dose strength, and whether generic pricing has been negotiated by that specific chain.

Insurance Coverage Comparison Table: